녹십자홀딩스

005250KOSPI회사 본부 및 경영 컨설팅 서비스업

45.5 / 100

Reference Date: 2026-07-24

Financial Score13.5 / 40

News Sentiment17.0 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is undervalued vs. peers but ROE is below the industry average. Declined 5.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Samsung Biologics Holdings Co., Ltd. is a holding company established in 2001, managing 54 subsidiaries across five business segments, including pharmaceuticals, diagnostics, and healthcare services. While the holding company oversees strategic planning and portfolio management, subsidiaries handle operational activities. The company has expanded its domestic and international revenue and asset base.

Number of Employees

163people

Average Salary

78.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 5.324.0Point

PBR

0.26Industry Average 0.324.0Point

In line with industry avg

ROE

-2.31Industry Average 4.070.0Point

Well below industry avg

Debt Ratio

39.54Industry Average 22.650.5Point

1.7x industry avg (risky)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲9.2% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲236.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -2.2% (improving, 3yr)

Detailed News Sentiment

7 totalPositive 3Neutral 3Negative 1Average Sentiment Score 67.9

Negative
IBK증권, 녹십자 목표가 하향…"2분기 영업익 기대치 하회 전망"
IBK투자증권의 녹십자 목표가 하향 조정으로 인해 주가에 부정적 영향 예상.
Neutral
녹십자, 하반기 회복해 연간 실적 지킬 듯…'매수'-IBK
IBK투자증권의 녹십자에 대한 매수 의견 유지에도 불구하고 목표주가 하향으로 인해 중립적인 시각을 보임.
Positive
허용준 녹십자홀딩스 대표 “'투트랙 전략'으로 글로벌 공략”
GC녹십자홀딩스는 글로벌 헬스케어 시장 진출을 위한 전략적 투자와 계열사의 기술력 강화를 통해 성장 동력을 확보하고 있다.

Detailed Momentum

52-week position1.0Point

Near 52w low (5%, downtrend)

Current 9,650Won52-week high 17,17052-week low 9,220

1-month return2.0Point

1m -5.58% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral[기재정정]타법인주식및출자증권처분결정(종속회사의주요경영사항)2026-07-09